Works matching Reverse transcriptase inhibitors
Results: 4357
Nucleoside reverse transcriptase inhibitor-reducing strategies in HIV treatment: assessing the evidence.
- Published in:
- HIV Medicine, 2018, v. 19, n. 1, p. 18, doi. 10.1111/hiv.12534
- By:
- Publication type:
- Article
Nucleoside Reverse Transcriptase Inhibitors Are the Major Class of HIV Antiretroviral Therapeutics That Induce Neuropathic Pain in Mice.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 16, p. 9059, doi. 10.3390/ijms25169059
- By:
- Publication type:
- Article
High-level resistance to non-nucleos(t)ide reverse transcriptase inhibitor based first-line antiretroviral therapy in Ghana; A 2017 study.
- Published in:
- Frontiers in Microbiology, 2022, v. 13, p. 1, doi. 10.3389/fmicb.2022.973771
- By:
- Publication type:
- Article
Current scenario on non-nucleoside reverse transcriptase inhibitors (2018-present).
- Published in:
- Arabian Journal of Chemistry, 2022, v. 15, n. 12, p. N.PAG, doi. 10.1016/j.arabjc.2022.104378
- By:
- Publication type:
- Article
Challenges and approaches in the discovery of human immunodeficiency virus type‐1 non‐nucleoside reverse transcriptase inhibitors.
- Published in:
- Medicinal Research Reviews, 2019, v. 39, n. 4, p. 1235, doi. 10.1002/med.21544
- By:
- Publication type:
- Article
Drug-resistance development differs between HIV-1-infected patients failing first-line antiretroviral therapy containing nonnucleoside reverse transcriptase inhibitors with and without thymidine analogues.
- Published in:
- HIV Medicine, 2013, v. 14, n. 9, p. 571, doi. 10.1111/hiv.12044
- By:
- Publication type:
- Article
Deep sequencing does not reveal additional transmitted mutations in patients diagnosed with HIV-1 variants with single nucleoside reverse transcriptase inhibitor resistance mutations.
- Published in:
- HIV Medicine, 2013, v. 14, n. 3, p. 176, doi. 10.1111/j.1468-1293.2012.01037.x
- By:
- Publication type:
- Article
Antiangiogenic VEGF165b Expression in Human Breast MCF-7 and MCF-10A Cells Exposed to Reverse Transcriptase and Protease Inhibitors.
- Published in:
- International Journal of Morphology, 2017, v. 35, n. 1, p. 148, doi. 10.4067/S0717-95022017000100024
- By:
- Publication type:
- Article
Reverse-transcriptase inhibitors for chronic hepatitis B.
- Published in:
- Geneesmiddelenbulletin, 2022, n. 11, p. 1, doi. 10.35351/gebu.2022.7.14
- By:
- Publication type:
- Article
Dolutegravir Plus Two Nucleoside Reverse Transcriptase Inhibitors versus Efavirenz Plus Two Nucleoside Reverse Transcriptase Inhibitors As Initial Antiretroviral Therapy for People with HIV: A Systematic Review.
- Published in:
- PLoS ONE, 2016, v. 11, n. 10, p. 1, doi. 10.1371/journal.pone.0162775
- By:
- Publication type:
- Article
Predictive Efficacy of Dual Therapies Combining Integrase Strand Transfer Inhibitors with Second-Generation Non-Nucleoside Reverse Transcriptase Inhibitors Following HIV-1 Treatment Failure in Cameroon: Implications for the Use of a Long-Acting Therapeutic Strategy in Low- and Middle-Income Countries
- Published in:
- Viruses (1999-4915), 2024, v. 16, n. 12, p. 1853, doi. 10.3390/v16121853
- By:
- Publication type:
- Article
Non-nucleoside reverse transcriptase inhibitors: a review on pharmacokinetics, pharmacodynamics, safety and tolerability.
- Published in:
- Journal of the International AIDS Society, 2013, v. 16, n. 1, p. 1, doi. 10.7448/IAS.16.1.18567
- By:
- Publication type:
- Article
HIV drug nucleoside reverse transcriptase inhibitors as promising anti-inflammation therapeutics by targeting P2X7-dependent large pore formation: one stone for two birds?
- Published in:
- 2015
- By:
- Publication type:
- Opinion
Evaluation of nucleoside reverse transcriptase inhibitor dosing during continuous veno-venous hemofiltration.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Nucleoside analog reverse transcriptase inhibitor induced lactic acidosis treated with continuous renal replacement in the medical intensive care unit.
- Published in:
- 2012
- By:
- Publication type:
- Case Study
Week 96 efficacy and safety of darunavir/ritonavir monotherapy vs. darunavir/ritonavir with two nucleoside reverse transcriptase inhibitors in the PROTEA trial.
- Published in:
- HIV Medicine, 2017, v. 18, n. 1, p. 5, doi. 10.1111/hiv.12386
- By:
- Publication type:
- Article
Costs of adverse events among patients with HIV infection treated with nonnucleoside reverse transcriptase inhibitors.
- Published in:
- HIV Medicine, 2014, v. 15, n. 8, p. 488, doi. 10.1111/hiv.12145
- By:
- Publication type:
- Article
No increased risk of hepatotoxicity in long-term use of nonnucleoside reverse transcriptase inhibitors in HIV-infected patients.
- Published in:
- HIV Medicine, 2012, v. 13, n. 7, p. 448, doi. 10.1111/j.1468-1293.2012.00995.x
- By:
- Publication type:
- Article
Synthesis and biological activity of new 6-benzylisocytosine derivatives: non-nucleoside HIV-1 reverse transcriptase inhibitors.
- Published in:
- Pharmaceutical Chemistry Journal, 2012, v. 46, n. 7, p. 397, doi. 10.1007/s11094-012-0808-y
- By:
- Publication type:
- Article
Is immune recovery different depending on the use of integrase strand transfer inhibitor-, non-nucleoside reverse transcriptase- or boosted protease inhibitor-based regimens in antiretroviral-naive HIV-infected patients?
- Published in:
- 2020
- By:
- Publication type:
- journal article
Liver Damage During Treatment with Reverse-Transcriptase Inhibitors in HIV Patients.
- Published in:
- Current Health Sciences Journal, 2024, v. 50, n. 2, p. 181, doi. 10.12865/CHSJ.50.02.03
- By:
- Publication type:
- Article
METHODS FOR MONITORING MITOCHONDRIAL TOXICITY OF NUCLEOSIDE-ANALOGUE REVERSE-TRANSCRIPTASE INHIBITORS IN HIV PATIENTS DURING ANTIRETROVIRAL THERAPY.
- Published in:
- Therapeutics, Pharmacology & Clinical Toxicology, 2011, v. 15, n. 4, p. 289
- By:
- Publication type:
- Article
Fluoride Pharmacokinetics in Urine and Plasma Following Multiple Doses of MK‐8507, an Investigational, Oral, Once‐Weekly Nonnucleoside Reverse Transcriptase Inhibitor.
- Published in:
- Journal of Clinical Pharmacology, 2022, v. 62, n. 2, p. 199, doi. 10.1002/jcph.1957
- By:
- Publication type:
- Article
Discovery of a semi-synthesized cyclolignan as a potent HIV-1 non-nucleoside reverse transcriptase inhibitor.
- Published in:
- Journal of Asian Natural Products Research, 2019, v. 21, n. 1, p. 76, doi. 10.1080/10286020.2017.1417266
- By:
- Publication type:
- Article
Determination of the Nucleoside Reverse Transcriptase Inhibitors Lamivudine, Stavudine, and Didanosine in Human Urine by Micellar Electrokinetic Chromatography Using the Ionic Liquid-Based Cationic Surfactant 1-Tetradecyl-3-Methylimidazolium Bromide.
- Published in:
- Analytical Letters, 2021, v. 54, n. 18, p. 2929, doi. 10.1080/00032719.2021.1904970
- By:
- Publication type:
- Article
DEVELOPMENT OF BENZIMIDAZOLE DERIVATIVES AS NON-NUCLEOSIDE HIV-1 REVERSE TRANSCRIPTASE INHIBITORS (REVIEW).
- Published in:
- Journal of Chemical Technology & Metallurgy, 2022, v. 57, n. 1, p. 3
- By:
- Publication type:
- Article
Spectrum of Non-Nucleoside Reverse Transcriptase Inhibitor-Associated Drug Resistance Mutations in Persons Living with HIV-1 Receiving Rilpivirine.
- Published in:
- Viruses (1999-4915), 2024, v. 16, n. 11, p. 1715, doi. 10.3390/v16111715
- By:
- Publication type:
- Article
Cardiometabolic Differences in People Living with HIV Receiving Integrase Strand Transfer Inhibitors Compared to Non-nucleoside Reverse Transcriptase Inhibitors: Implications for Current ART Strategies.
- Published in:
- Viruses (1999-4915), 2024, v. 16, n. 4, p. 582, doi. 10.3390/v16040582
- By:
- Publication type:
- Article
Profiling the Interaction between Human Serum Albumin and Clinically Relevant HIV Reverse Transcriptase Inhibitors.
- Published in:
- Viruses (1999-4915), 2024, v. 16, n. 4, p. 491, doi. 10.3390/v16040491
- By:
- Publication type:
- Article
The Application of Prodrugs as a Tool to Enhance the Properties of Nucleoside Reverse Transcriptase Inhibitors.
- Published in:
- Viruses (1999-4915), 2023, v. 15, n. 11, p. 2234, doi. 10.3390/v15112234
- By:
- Publication type:
- Article
Mechanistic Study of Common Non-Nucleoside Reverse Transcriptase Inhibitor-Resistant Mutations with K103N and Y181C Substitutions.
- Published in:
- Viruses (1999-4915), 2016, v. 8, n. 10, p. 263, doi. 10.3390/v8100263
- By:
- Publication type:
- Article
Coenzyme Q10 Alleviates Chronic Nucleoside Reverse Transcriptase Inhibitor-Induced Premature Endothelial Senescence.
- Published in:
- Cardiovascular Toxicology, 2019, v. 19, n. 6, p. 500, doi. 10.1007/s12012-019-09520-1
- By:
- Publication type:
- Article
Nucleoside Reverse Transcriptase Inhibitors Induce a Mitophagy-Associated Endothelial Cytotoxicity That Is Reversed by Coenzyme Q10 Cotreatment.
- Published in:
- Toxicological Sciences, 2013, v. 134, n. 2, p. 323, doi. 10.1093/toxsci/kft105
- By:
- Publication type:
- Article
LB9. The Effect of Initiating Integrase Inhibitor-based vs. Non-Nucleoside Reverse Transcriptase Inhibitor-based Antiretroviral Therapy on Progression to Diabetes among North American Persons in HIV Care.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S996, doi. 10.1093/ofid/ofz415.2492
- By:
- Publication type:
- Article
Non-Nucleoside Reverse Transcriptase Inhibitors Join Forces with Integrase Inhibitors to Combat HIV.
- Published in:
- Pharmaceuticals (14248247), 2020, v. 13, n. 6, p. 122, doi. 10.3390/ph13060122
- By:
- Publication type:
- Article
Treatment outcomes of integrase inhibitors, boosted protease inhibitors and nonnucleoside reverse transcriptase inhibitors in antiretroviral‐naïve persons starting treatment.
- Published in:
- HIV Medicine, 2020, v. 21, n. 9, p. 599, doi. 10.1111/hiv.12888
- By:
- Publication type:
- Article
Comparison of 48‐week efficacies of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide and nucleoside/nucleotide reverse transcriptase inhibitor‐sparing regimens: a systematic review and network meta‐analysis.
- Published in:
- HIV Medicine, 2018, v. 19, n. 8, p. 559, doi. 10.1111/hiv.12643
- By:
- Publication type:
- Article
Protection of Retinal Function by Nucleoside Reverse Transcriptase Inhibitors Following Retinal Ischemia/Reperfusion Injury.
- Published in:
- 2021
- By:
- Publication type:
- journal article
No accelerated progression of subclinical atherosclerosis with integrase strand transfer inhibitors compared to non-nucleoside reverse transcriptase inhibitors.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2025, v. 80, n. 1, p. 126, doi. 10.1093/jac/dkae383
- By:
- Publication type:
- Article
Nucleoside Reverse Transcriptase Inhibitor Exposure Is Associated with Lower Alzheimer's Disease Risk: A Retrospective Cohort Proof-of-Concept Study.
- Published in:
- Pharmaceuticals (14248247), 2024, v. 17, n. 4, p. 408, doi. 10.3390/ph17040408
- By:
- Publication type:
- Article
Molecular Modeling, Synthesis, and Anti- HIV Activity of Novel Isoindolinedione Analogues as Potent Non-nucleoside Reverse Transcriptase Inhibitors.
- Published in:
- Chemical Biology & Drug Design, 2016, v. 87, n. 2, p. 200, doi. 10.1111/cbdd.12620
- By:
- Publication type:
- Article
Synthesis and Biological Evaluation of 2-Thioxopyrimidin-4(1H)-one Derivatives as Potential Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors.
- Published in:
- International Journal of Molecular Sciences, 2014, v. 15, n. 11, p. 20723, doi. 10.3390/ijms151120723
- By:
- Publication type:
- Article
Identification of novel bifunctional HIV-1 reverse transcriptase inhibitors.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Randomized, placebo-controlled single-ascending-dose study to evaluate the safety, tolerability and pharmacokinetics of the HIV nucleoside reverse transcriptase inhibitor, BMS-986001, in healthy subjects.
- Published in:
- Journal of Clinical Pharmacology, 2014, v. 54, n. 6, p. 657, doi. 10.1002/jcph.252
- By:
- Publication type:
- Article
Nucleoside Reverse Transcriptase Inhibitor Resistance Mutations Associated with First-Line Stavudine-Containing Antiretroviral Therapy: Programmatic Implications for Countries Phasing Out Stavudine.
- Published in:
- Journal of Infectious Diseases, 2013, v. 207, n. suppl_2, p. S70, doi. 10.1093/infdis/jit114
- By:
- Publication type:
- Article
Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: programmatic implications for countries phasing out stavudine.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Investigation of drug resistance against protease, reverse transcriptase, and integrase inhibitors by next‐generation sequencing in HIV‐positive patients.
- Published in:
- Journal of Medical Virology, 2021, v. 93, n. 6, p. 3627, doi. 10.1002/jmv.26582
- By:
- Publication type:
- Article
Molecular Analysis of Mitochondrial Compromise in Rodent Cardiomyocytes Exposed Long Term to Nucleoside Reverse Transcriptase Inhibitors (NRTIs).
- Published in:
- Cardiovascular Toxicology, 2012, v. 12, n. 2, p. 123, doi. 10.1007/s12012-011-9148-5
- By:
- Publication type:
- Article
Phase I/II study of the pharmacokinetics, safety and antiretroviral activity of tenofovir alafenamide, a new prodrug of the HIV reverse transcriptase inhibitor tenofovir, in HIV-infected adults.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2014, v. 69, n. 5, p. 1362, doi. 10.1093/jac/dkt532
- By:
- Publication type:
- Article
Clinical benefits of novel non‐nucleoside reverse transcriptase inhibitors: A prospective cohort study.
- Published in:
- Immunity, Inflammation & Disease, 2024, v. 12, n. 4, p. 1, doi. 10.1002/iid3.1217
- By:
- Publication type:
- Article